Skip to main content
. 2009 Dec 7;14(Suppl 4):265–267. doi: 10.1186/2047-783X-14-S4-265

Table 1.

Baseline characteristics.

Baseline Characteristics Co-trimoxazole Group (n = 16) Placebo Group (n = 15)
Median age (yr) 46.1 (21.1-56.5) 51.4 (28.4-76.0)
Sex (M/F) 8/8 7/8
Disease duration (mo) 67 (8-86) 66 (7-71)
BVAS-WG 8 (2-11) 11 (12-14)
DEI 4 (3-8) 5 (3-7)
GFR (ml/min) 81 (74-110) 71 (486-88)
Length of remission (mo) 15 16
Positive serum test for PR3 at the start of treatment 7 9